- General
-
Genetic Susceptibility of ACE2 and TMPRSS2 in Six Common Cancers and Possible Impacts on COVID-19
-
Tung Hoang, Trung Quang Nguyen, Tho Thi Anh Tran
-
Cancer Res Treat. 2021;53(3):650-656. Published online December 29, 2020
-
DOI: https://doi.org/10.4143/crt.2020.950
-
-
 Abstract
 PDF Supplementary Material PubReader ePub
- Purpose
Coronavirus disease 2019 (COVID-19) pandemic has spread worldwide rapidly and patients with cancer have been considered as a vulnerable group for this infection. This study aimed to examine the expressions of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) in tumor tissues of six common cancer types.
Materials and Methods
The expression levels of ACE2 and TMPRSS2 in tumors and control samples were obtained from online databases. Survival prognosis and biological functions of these genes were investigated for each tumor type.
Results
There was the overexpression of ACE2 in colon and stomach adenocarcinomas compared to controls, meanwhile colon and prostate adenocarcinomas showed a significantly higher expression of TMPRSS2. Additionally, survival prognosis analysis has demonstrated that upregulation of ACE2 in liver hepatocellular carcinoma was associated with higher overall survival (hazard ratio, 0.65; p=0.016) and disease-free survival (hazard ratio, 0.66; p=0.007), while overexpression of TMPRSS2 was associated with a 26% reduced risk of death in lung adenocarcinoma (p=0.047) but 50% increased risk of death in breast invasive carcinoma (p=0.015).
Conclusion
There is a need to take extra precautions for COVID-19 in patients with colorectal cancer, stomach cancer, and lung cancer. Further information on other types of cancer at different stages should be investigated.
-
Citations
Citations to this article as recorded by  - In vitro analysis suggests that SARS-CoV-2 infection differentially modulates cancer-like phenotypes and cytokine expression in colorectal and prostate cancer cells
Alberta Serwaa, Fatima Oyawoye, Irene Amoakoh Owusu, Daniel Dosoo, Aaron Adom Manu, Augustine Kojo Sobo, Kwadwo Fosu, Charles Ochieng Olwal, Peter Kojo Quashie, Anastasia Rosebud Aikins
Scientific Reports.2024;[Epub] CrossRef - Impacts of COVID-19 in Breast Cancer: From Molecular Mechanism to
the Treatment Approach
Maria Carolina Stipp, Claudia Rita Corso, Alexandra Acco
Current Pharmaceutical Biotechnology.2023; 24(2): 238. CrossRef - A Multigene-Panel Study Identifies Single Nucleotide Polymorphisms Associated with Prostate Cancer Risk
Maria Antonietta Manca, Fabio Scarpa, Davide Cossu, Elena Rita Simula, Daria Sanna, Stefano Ruberto, Marta Noli, Hajra Ashraf, Tatiana Solinas, Massimo Madonia, Roberto Cusano, Leonardo A. Sechi
International Journal of Molecular Sciences.2023; 24(8): 7594. CrossRef - Covid-19 And Cancer: Insights Into Their Association And Influence On Genetic And Epigenetic Landscape
Mrinal K Ghosh, Sunny Kumar, Kirat K Ganguly, Pratyay Ghosh, Shaheda Tabassum, Bhaskar Basu, Malini Basu
Epigenomics.2023; 15(4): 227. CrossRef - Bioinformatics approach to identify common gene signatures of patients with coronavirus 2019 and lung adenocarcinoma
Xiao Liang, Yali Chen, Yuchao Fan
Environmental Science and Pollution Research.2022; 29(15): 22012. CrossRef - Multi‐omics of the expression and clinical outcomes of TMPRSS2 in human various cancers: A potential therapeutic target for COVID‐19
Li Liu, Ju‐Fang Qin, Man‐Zhen Zuo, Quan Zhou
Journal of Cellular and Molecular Medicine.2022; 26(3): 709. CrossRef - A Novel Prognostic Signature for Survival Prediction and Immune Implication Based on SARS-CoV-2–Related Genes in Kidney Renal Clear Cell Carcinoma
Yongbiao Huang, Sheng Chen, Lingyan Xiao, Wan Qin, Long Li, Yali Wang, Li Ma, Xianglin Yuan
Frontiers in Bioengineering and Biotechnology.2022;[Epub] CrossRef - Potential therapeutic strategies for quercetin targeting critical pathological mechanisms associated with colon adenocarcinoma and COVID-19
Xiushen Li, Weizheng Liang, Chengwei Yu, Qingxue Meng, Weiwen Zhang, Xueliang Wu, Jun Xue, Shoulong Deng, Hao Wang
Frontiers in Pharmacology.2022;[Epub] CrossRef - Assessing the Vulnerability of Cancer Patients for COVID-19
Saloni Bhatia, Padmini Gokhale, Teesta Katte, Shreeshanthi Acharya, Avinash Arvind Rasalkar, Soumya Vidapanakal, Ram Manas, Sampath Chinnam, Prathibha Narayanan, Ashok Kumar Shettihalli, Vijayakumar Kadappa, Divijendra Natha Reddy Sirigiri
ACS Omega.2022; 7(40): 35735. CrossRef - Biological effects of COVID-19 on lung cancer: Can we drive our decisions
Beatrice Aramini, Valentina Masciale, Anna Valeria Samarelli, Roberto Tonelli, Stefania Cerri, Enrico Clini, Franco Stella, Massimo Dominici
Frontiers in Oncology.2022;[Epub] CrossRef - COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario
Shomoita Sayed
Cancer Treatment and Research Communications.2021; 28: 100425. CrossRef - Neuropilin-1: A feasible link between liver pathologies and COVID-19
Aitor Benedicto, Iñigo García-Kamiruaga, Beatriz Arteta
World Journal of Gastroenterology.2021; 27(24): 3516. CrossRef
-
8,701
View
-
214
Download
-
12
Web of Science
-
12
Crossref
|
KCA
